Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Arthritis Rheumatol. 2019 Feb 28;71(4):496–506. doi: 10.1002/art.40771

Figure 3: Adjusted Mean Global Myocardial FDG Uptake According to CDAI and Current Biologic DMARD Use.

Figure 3:

Means and 95% confidence intervals are depicted. Panel A and B are adjusted for DMARD treatment and RA disease group (controlled vs uncontrolled) which were the only significant covariates retained in multivariable modeling. CDAI: Clinical Disease Activity Index, TNF-i: Tumor Necrosis Factor inhibitor. SUV: Standardize Uptake Value